Abbott Laboratories adopted new By-Laws at the Annual Meeting on April 11, 1963.
The By-Laws were further amended and restated effective December 12, 2025.
Key provisions in the By-Laws address the Corporation's offices and shareholder meetings.
Annual Meeting
Shareholders hold annual meetings to elect Directors and conduct other business specified in the By-Laws.
Shareholder Nominations
Nominations for Directors and proposals for business must be properly brought before the annual meeting.
Notice Requirements
Shareholders must adhere to specific notice requirements for making nominations and proposing business at annual meetings.
- The By-Laws set clear guidelines for the annual shareholder meetings and the nomination process.
- Proper adherence to the By-Laws ensures transparency and accountability in governance practices.
The review of Abbott Laboratories' By-Laws showcases the importance of structured corporate governance practices in maintaining transparency and accountability.